Stand Up to Cancer hosts third fundraising telecast

Article

Mark you calendars for Sept. 7. You're going to want to tune in for the third Stand Up to Cancer broadcast. The one-hour fundraising show will feature celebrity actors, musicians and athletes to raise money for cancer research. The event will be broadcast commercial-free on ABC, CBS, FOX, NBC and cable stations at 7 p.m. Central.This will be the first SU2C event since the death of co-founder and executive producer Laura Ziskin from breast cancer last year - "Laura Ziskin's legacy of Stand Up to Cancer lives on." The first two telecasts, which aired in 2008 and 2010, have raised more than $180 million for SU2C's cancer research grants that have funded seven "Dream Teams." These researchers are collaborating on innovative ideas that will spur cancer advancements. (Wondering where all that research money goes? Wonder why we haven't seen a cure? Read Stand Up to Cancer: Will you be watching?)I was fortunate to meet one patient who has already benefited from this research back in April at the American Association for Cancer Research annual meeting. (AACR is the scientific partner to SU2C.) Jeannette Daniel had been diagnosed with metastatic breast cancer patient and had enrolled in one of the PI3K pathway-focused clinical trials funded by SU2C. She spoke at the AACR-SU2C press briefing and recounted how hopeless and angry she had been when was told to prepare for the worst. She has since been declared cancer-free. While not typical, her story is incredibly inspirational and shows the power of how clinical studies of innovative ideas can progress research. Score one for SU2C.For more detailed information on the telecast, the scientific Dream Teams, individual research grants and other SU2C activities, go to standup2cancer.org.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content